[Ruxolitinib in the treatment of two cases of chronic neutrophilic leukemia]

Zhonghua Zhong Liu Za Zhi. 2020 Feb 23;42(2):113-114. doi: 10.3760/cma.j.issn.0253-3766.2020.02.005.

[Article in Chinese]

Authors

W S Zheng¹, L X Guan¹, L C Cheng¹, Y L Hu¹, Y Y Xu¹, T Yang¹, B Peng², Y L Wu², J Bo², Q S Wang², X N Gao²

Affiliations

¹ Department of Hematology, Hainan Hospital of Chinese PLA General Hospital, Sanya 572000, China.
² Department of Hematology, Chinese PLA General Hospital, Beijing 100853, China.

PMID: 32135644
DOI: 10.3760/cma.j.issn.0253-3766.2020.02.005

No abstract available

Keywords: Chronic neutrophilic leukemia; Colony stimulating factor 3 receptor; Ruxolitinib.

Publication types

Case Reports

MeSH terms

Humans
Leukemia, Neutrophilic, Chronic / drug therapy*
Nitriles
Pyrazoles / therapeutic use*
Pyrimidines

Substances

Nitriles
Pyrazoles
Pyrimidines
ruxolitinib